Clinical Trial Update: Phase II Study of Cetuximab in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase II trial evaluating cetuximab in combination with carboplatin and docetaxel for patients with advanced non-small c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• ERBITUX (cetuximab)
• Taxotere (docetaxel)

Snippet

Sponsor: Veeda Oncology | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 2 | Status: COMPLETED